Edward Eden

St. Luke's-Roosevelt Hospital Center

Papers

1

Total Citations

343

H-Index

1

About

Dr. Edward Eden is a leading pulmonary researcher whose work has fundamentally advanced our understanding of how inhaled substances—from tobacco to electronic nicotine delivery systems—drive chronic lung disease. His research focuses on the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD) and the pulmonary toxicology of emerging nicotine products. Dr. Eden’s most impactful contribution is a landmark 2016 study, cited over 340 times, which provided the first robust experimental evidence that chronic electronic cigarette exposure can induce COPD-like pathology in a nicotine-dependent manner. This work was pivotal in shifting the scientific conversation from whether e-cigarettes are “safer” than cigarettes to understanding their unique and independent risks. Beyond this, his broader body of work has elucidated the mechanisms by which cigarette smoke and nicotine alter airway structure and immune function, directly informing clinical guidelines on smoking cessation and vaping regulation. Dr. Eden’s research is distinguished by its translational power, using rigorous animal models to answer questions that would take decades to resolve in human populations. His findings continue to shape public health policy and clinical practice, making him a critical voice in the fight against tobacco-related disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
343
Total Citations
343
Avg Citations/Paper
🏆 Most Cited Paper
Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner
343 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: St. Luke's-Roosevelt Hospital Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago